Ardent Health Partners, LLC (NYSE: ARDT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.
LowReport
Ardent Health Partners, LLC (NYSE: ARDT) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $23.00 price target on the stock.
Ardent Health Partners, LLC (NYSE: ARDT) had its price target raised by analysts at Leerink Partners from $23.00 to $25.00. They now have an "outperform" rating on the stock.
LowReport
Ardent Health Partners, LLC (NYSE: ARDT) had its price target raised by analysts at Leerink Partners from $23.00 to $25.00. They now have an "outperform" rating on the stock.
Ardent Health Partners, LLC (NYSE: ARDT) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $19.00 price target on the stock, down previously from $22.00.
LowReport
Ardent Health Partners, LLC (NYSE: ARDT) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $19.00 price target on the stock, down previously from $22.00.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: